Gianfilippo Bertelli

6.6k total citations
107 papers, 2.2k citations indexed

About

Gianfilippo Bertelli is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gianfilippo Bertelli has authored 107 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 37 papers in Cancer Research and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gianfilippo Bertelli's work include Cancer Treatment and Pharmacology (34 papers), Breast Cancer Treatment Studies (29 papers) and Estrogen and related hormone effects (21 papers). Gianfilippo Bertelli is often cited by papers focused on Cancer Treatment and Pharmacology (34 papers), Breast Cancer Treatment Studies (29 papers) and Estrogen and related hormone effects (21 papers). Gianfilippo Bertelli collaborates with scholars based in United Kingdom, Italy and Australia. Gianfilippo Bertelli's co-authors include P. Pronzato, M. Venturini, Lucia Del Mastro, R. Rosso, Ornella Garrone, D. Dini, Alberto Gozza, D. Amoroso, Pierfranco Conté and Robert Leonard and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Gianfilippo Bertelli

104 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gianfilippo Bertelli United Kingdom 27 1.3k 563 421 364 311 107 2.2k
M. Venturini Italy 25 1.3k 1.0× 371 0.7× 145 0.3× 281 0.8× 299 1.0× 87 1.9k
Carolien H. Smorenburg Netherlands 27 1.6k 1.2× 551 1.0× 200 0.5× 541 1.5× 173 0.6× 99 3.0k
Reena S. Cecchini United States 20 1.8k 1.4× 959 1.7× 1.1k 2.5× 422 1.2× 125 0.4× 49 2.9k
Adnan Aydıner Türkiye 25 1.0k 0.8× 295 0.5× 127 0.3× 473 1.3× 102 0.3× 156 2.3k
B Chevallier France 21 1.2k 0.9× 490 0.9× 142 0.3× 227 0.6× 176 0.6× 68 1.8k
Maddalena Barba Italy 34 921 0.7× 388 0.7× 193 0.5× 471 1.3× 100 0.3× 118 3.3k
Shozo Ohsumi Japan 27 1.2k 1.0× 701 1.2× 407 1.0× 373 1.0× 356 1.1× 134 2.5k
Mark Lansdown United Kingdom 19 711 0.6× 428 0.8× 551 1.3× 298 0.8× 76 0.2× 45 1.8k
Halle C. F. Moore United States 22 1.0k 0.8× 387 0.7× 127 0.3× 415 1.1× 89 0.3× 88 1.6k
P E Preece United Kingdom 21 624 0.5× 629 1.1× 373 0.9× 156 0.4× 98 0.3× 53 1.5k

Countries citing papers authored by Gianfilippo Bertelli

Since Specialization
Citations

This map shows the geographic impact of Gianfilippo Bertelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianfilippo Bertelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianfilippo Bertelli more than expected).

Fields of papers citing papers by Gianfilippo Bertelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianfilippo Bertelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianfilippo Bertelli. The network helps show where Gianfilippo Bertelli may publish in the future.

Co-authorship network of co-authors of Gianfilippo Bertelli

This figure shows the co-authorship network connecting the top 25 collaborators of Gianfilippo Bertelli. A scholar is included among the top collaborators of Gianfilippo Bertelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianfilippo Bertelli. Gianfilippo Bertelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hall, Marcia, Gianfilippo Bertelli, Clare Green, et al.. (2019). Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study. International Journal of Gynecological Cancer. 30(2). 213–220. 19 indexed citations
3.
Muthukrishnan, Arvind, Saad Al‐Ismail, Gianfilippo Bertelli, & Paul Browne. (2017). MRONJ risk reduction pathway - 360 degree survey. BDJ. 222(5). 386–390. 4 indexed citations
4.
5.
Bertelli, Gianfilippo, et al.. (2013). Biomarkers in the Management of Breast Cancer. Applied immunohistochemistry & molecular morphology. 21(6). 481–484. 1 indexed citations
6.
Bertelli, Gianfilippo, Ian M. Humphreys, William J. Valentine, et al.. (2013). A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK. British Journal of Cancer. 108(11). 2250–2258. 77 indexed citations
7.
Lewis, Paul D., et al.. (2012). Decision-making tools to assist prognosis and treatment choices in early breast cancer: a review. Expert Review of Anticancer Therapy. 12(8). 1033–1043. 4 indexed citations
8.
Bertelli, Gianfilippo, et al.. (2009). Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women. SHILAP Revista de lepidopterología. 2 indexed citations
9.
10.
Bertelli, Gianfilippo, et al.. (2004). Sentinel lymph node biopsy in breast cancer patients: The medical oncology perspective. Journal of Surgical Oncology. 85(3). 129–132. 14 indexed citations
11.
Bertelli, Gianfilippo, M. Venturini, Lucia Del Mastro, et al.. (2002). Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study. Annals of Oncology. 13(6). 883–888. 73 indexed citations
12.
Angiolini, Catia, M. Venturini, Lucia Del Mastro, et al.. (2000). Capecitabine in association with epirubicin and docetaxel as first line chemotherapy in advanced breast cancer A dose-finding study. Breast Cancer Research and Treatment. 64(1). 123. 8 indexed citations
13.
Venturini, M., Paolo Bruzzi, Lucia Del Mastro, et al.. (1996). Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.. Journal of Clinical Oncology. 14(3). 764–773. 45 indexed citations
14.
Pronzato, P., et al.. (1996). A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer. British Journal of Cancer. 73(11). 1425–1427. 8 indexed citations
15.
Sertoli, M.R., Paolo Bruzzi, P. Pronzato, et al.. (1995). Randomized cooperative study of perioperative chemotherapy in breast cancer.. Journal of Clinical Oncology. 13(11). 2712–2721. 27 indexed citations
16.
Pronzato, P., A. Rubagotti, D. Amoroso, et al.. (1993). Second-Line Hormonotherapy for Breast Cancer. American Journal of Clinical Oncology. 16(6). 522–525. 8 indexed citations
17.
Dini, D., et al.. (1991). Irrigation for colostomized cancer patients: a rational approach. International Journal of Colorectal Disease. 6(1). 9–11. 10 indexed citations
18.
Amoroso, D., P. Pronzato, Gianfilippo Bertelli, et al.. (1988). Cisplatin and 5-fluorouracil in refractory breast cancer patients: A phase II study. Breast Cancer Research and Treatment. 11(3). 269–271. 5 indexed citations
19.
Bertelli, Gianfilippo, P. Pronzato, D. Amoroso, et al.. (1988). Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levels. Breast Cancer Research and Treatment. 12(3). 307–310. 105 indexed citations
20.
Lionetto, Rita, P. Pronzato, Pierfranco Conté, et al.. (1987). Multimodality Treatment of Locally Advanced Breast Cancer. Oncology. 44(3). 137–141. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Venturini Breakdown of academic impact, for papers by Carolien H. Smorenburg Breakdown of academic impact, for papers by Reena S. Cecchini Breakdown of academic impact, for papers by Adnan Aydıner Breakdown of academic impact, for papers by B Chevallier Breakdown of academic impact, for papers by Maddalena Barba Breakdown of academic impact, for papers by Shozo Ohsumi Breakdown of academic impact, for papers by Mark Lansdown Breakdown of academic impact, for papers by Halle C. F. Moore Breakdown of academic impact, for papers by P E Preece
Rankless by CCL
2026